News

Personalized Immune Cell Treatment NKCL Classic

GK Global Group Co., Ltd. and G-ASSET are newly participating as Venture Capital of NKCL Bio Group.

NKCL 2022.04.25 18:32

photo_2022-04-25_18-24-47.jpg

photo_2022-04-25_18-23-47.jpg

GK Global Group Co., Ltd. and G-ASSET are newly participating as Venture Capital of NKCL Bio Group.


Attach Files
  1. 1414.png